↓ Skip to main content

Dove Medical Press

Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss – results of an exploratory study

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, May 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
58 Mendeley
Title
Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss – results of an exploratory study
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, May 2019
DOI 10.2147/dmso.s182953
Pubmed ID
Authors

Ijeoma M Muo, Sandra D MacDonald, Ritu Madan, Sung-Jun Park, Ahmed M Gharib, Pedro E. Martinez, Mary F Walter, Shanna B Yang, Justin A Rodante, Amber B Courville, Peter J Walter, Hongyi Cai, Michael Glicksman, Gioia M Guerrieri, Rivka R Ben-Dor, Ronald Ouwerkerk, Stephanie Mao, Jay H Chung

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 17%
Researcher 8 14%
Student > Master 5 9%
Unspecified 4 7%
Student > Ph. D. Student 3 5%
Other 8 14%
Unknown 20 34%
Readers by discipline Count As %
Medicine and Dentistry 10 17%
Nursing and Health Professions 8 14%
Unspecified 4 7%
Biochemistry, Genetics and Molecular Biology 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 4 7%
Unknown 28 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2019.
All research outputs
#17,350,971
of 25,462,162 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#611
of 1,184 outputs
Outputs of similar age
#232,042
of 363,620 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#16
of 27 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,620 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.